Univariate analysis did not find significant differences of iDFS rates among patients with different ages, menopausal statuses, pathological types, tumor grades, tumor sizes, HER2 statuses, or Ki67 levels (P>0.05) (Table 3). Here, ERBB2 is linked to neoplasm.